The global market for artificial intelligence in healthcare is expanding rapidly – estimated at $39.25 billion in 2025, expected to grow to $504.17 billion by 2032[1]. North America already holds nearly 50% of this market, meaning most of the expansion will take place in US healthcare systems[1]. Payment for clinical AI is gradually being formalized – the American Medical Association is introducing the CMAA (Clinically Meaningful Algorithmic Analyzes) framework and CMS is preparing new payments for new technologies (NTAP), which should be active in 2026[2]. A new CMS program called ACCESS (Advancing Chronic Care with Effective, Scalable Solutions) launched in 2026 shifts the focus to complex and costly care, with technology becoming a key part of the business model[2]. Major players include large technology platforms (Microsoft, Google, Amazon) that provide cloud solutions and AI tools, and insurance companies with tools for automating claims approval and billing analytics[1]. Investors have poured an estimated $10.7 billion into AI healthcare technologies in 2025, a 24% increase over 2024 as a whole[4]. High quality data is becoming the most strategic asset in healthcare for patients, providers, insurance companies and governments[4].